In focus · trending topic

Minerva Neurosciences

65 stories · following the connections

Minerva Neurosciences Announces Positive Top Line Results From Phase Ib Clinical Trial in Major Depressive Disorder With MIN-202

By Nasdaq OMXMar 11, 2016, 1:30 PM UTC